Enliven Therapeutics Inc. (ELVN)

Enliven Therapeutics Inc. (ELVN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.9B; returns 1 day -1.0%, 1 week +11.3%, 1 year +102.0%.

Enliven Therapeutics Inc. (ELVN) is a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation small molecule therapeutics, employing a precision oncology approach to address unmet needs in cancer treatment.

Groups ELVN belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Healthcare
• Precision Medicine
• Clinical Stage Biopharma
• Life Sciences
• Biopharmaceutical
• Drug Discovery
• Cancer Therapeutics

ELVN financial model: income statement, cash flow and balance sheet